RBC Capital downgrades MannKind stock rating on royalty concerns

try{ var _=i o; . if(!_||_&&typeof _==="object"&&_.expiry Gold prices jump 2% amid widening US-Israel conflict with Iran Asia stocks slide as US-Iran strikes batter risk appetite Middle East tensions rise as Iran promises retaliation $100+ oil back in play if Hormuz disruption worsens: analysts (South Africa Philippines Nigeria) RBC Capital downgrades MannKind stock rating on royalty concerns By Investing.com Analyst Ratings Published 03/02/2026, 03:24 AM RBC Capital downgrades MannKind stock rating on royalty concerns 0 MNKD 1.23% UTHR 0.06% Investing.com - RBC Capital downgraded MannKind (NASDAQ:MNKD) to Sector Perform from Outperform and cut its price target to $3.50 from $7.50. The stock has plunged 41% over the past week, trading at $3.28 with a market cap of $1.01 billion. The firm said it is downgrading the shares as it awaits further clarity on the Tyvaso DPI royalty outlook and the degree of revenue inflection associated with potential approvals for pediatric Afrezza and the FUROSCIX autoinjector. United Therapeutics ’ pursuit to launch a SMI treprostinil device, if approved, in 2027 and an apparent decision to not conduct IPF bridging studies present significant risks to MannKind ’s Tyvaso DPI royalties and collaboration revenues, RBC Capital said. Data on the Tyvaso DPI royalty outlook is not expected to be available until 2027, the firm noted. MannKind’s dependence on United Therapeutics and Tyvaso DPI has decreased following the SCPH acquisition, though United Therapeutics revenues still contributed approximately 53% to fourth-quarter 2025 revenues, RBC Capital said. In other recent news, MannKind Corporation reported its fourth-quarter 2025 earnings, revealing a mixed financial performance. The company achieved a revenue of $112 million, surpassing forecasts by 14.35%. However, MannKind’s earnings per share fell short, reporting $0.01 compared to the expected $0.02. Despite the EPS miss, the strong revenue growth seemed to drive positive sentiment amon...